Holen Sie sich die Stockscreener-App
1.08
0.92%
-0.01
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Pliant Therapeutics Inc (PLRX) Income Statement - TradingKey
Pliant Therapeutics Inc (PLRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pliant Therapeutics Inc (PLRX) Cash Flow - TradingKey
Pliant Therapeutics Inc (PLRX) Balance Sheet - TradingKey
Pliant Therapeutics Inc (PLRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pliant Therapeutics Inc (PLRX) Institutional Confidence - TradingKey
Pliant Therapeutics Inc (PLRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PLRX|Pliant Therapeutics Inc|Price:1.080|Chg%:-0.010 - TradingKey
PLRX|Pliant Therapeutics Inc|Price:1.090|Chg%:+0.010 - TradingKey
Pliant Therapeutics Inc (PLRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pliant Therapeutics Inc (PLRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pliant Therapeutics Inc (PLRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pliant Therapeutics, Inc. Files Form 8-K with SEC Detailing Company Information and NASDAQ Listing - Minichart
Form 4 Pliant Therapeutics Inc For: 13 July By Investing.com - Investing.com Nigeria
Pliant Therapeutics adds independent directors to strengthen R&D - TipRanks
Pliant Therapeutics (PLRX) director Robert Iannone submits initial Form 3 - Stock Titan
Pliant Therapeutics (PLRX) director files initial insider ownership statement - Stock Titan
Pliant Therapeutics (PLRX) awards 60,000 stock options to director Flavia Borellini - Stock Titan
[8-K] PLIANT THERAPEUTICS, INC. Reports Material Event - Stock Titan
Pliant Therapeutics adds two directors with oncology expertise - Investing.com UK
Pliant Therapeutics appoints Flavia Borellini to board, strengthening executive leadership - Traders Union
Pliant Therapeutics adds two directors with oncology expertise By Investing.com - Investing.com Nigeria
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors - The Manila Times
Price to sales forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView
Price to earnings forward of Pliant Therapeutics, Inc. – FWB:9PT - TradingView
Price to book forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView
Enterprise value to revenue forward of Pliant Therapeutics, Inc. – FWB:9PT - TradingView
Enterprise value to revenue forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView
Price to earnings forward of Pliant Therapeutics, Inc. – TRADEGATE:9PT - TradingView
Pliant Therapeutics (PLRX) Stock Edges Lower, Holds Closely Above Key SupportAccumulation Line - dars.gov.et
Pliant Therapeutics (PLRX) Holds Steady at $1.17 as Traders Eye Key Support and Resistance LevelsVolume Dry Up - dars.gov.et
Enterprise value to EBITDA forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView
Enterprise value to EBITDA forward of Pliant Therapeutics, Inc. – GETTEX:9PT - TradingView
Pliant Therapeutics Inc. (PLRX) Q1 2026 Earnings: Narrower Loss Sends Stock HigherTech Earnings Analysis - dars.gov.et
Pliant Therapeutics (PLRX) Edges Higher Amid Consolidation Near SupportPre-Earnings Momentum - dars.gov.et
Pliant Therapeutics Inc. (PLRX) Q1 2026 Earnings: EPS Beat Highlights Cost DisciplineSegment Revenue Breakdown - dars.gov.et
PLRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Pliant Therapeutics (PLRX) Inches Higher Amid Ongoing Volatility: Key Levels to WatchMerger Arbitrage - dars.gov.et
Pliant Therapeutics Inc (PLRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
9PT Forecast — Price Target — Prediction for 2027 - TradingView
Pliant Therapeutics, Inc. Actuals & Estimates (NASDAQ:PLRX) - TradingView
PLRX Forecast — Price Target — Prediction for 2027 - TradingView
Pliant Therapeutics (PLRX) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress ContinuesManagement Guidance Update - DonanımHaber
Pliant Therapeutics Inc (PLRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PLRX SEC FilingsPliant Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Pliant Therapeutics (PLRX) director receives 70,000 stock options at $1.14 - Stock Titan
Pliant Therapeutics (PLRX) director granted 70,000 options at $1.14 strike - Stock Titan
Pliant Therapeutics (PLRX) director receives 70,000-share stock option grant - Stock Titan
Pliant (NASDAQ: PLRX) director awarded 70,000 stock options at $1.14 - Stock Titan
PLIANT THERAPEUTICS (PLRX) director granted 70,000 stock options at $1.14 - Stock Titan
Director Darren Cline receives 70,000 PLRX stock options at $1.14 strike price - Stock Titan
Pliant Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huh Hoyoung - Moomoo
Pliant Therapeutics Shareholders Approve Directors and Executive Pay - TipRanks
Pliant Therapeutics (NASDAQ: PLRX) reports 2026 director, pay and auditor votes - Stock Titan
PLIANT THERAPEUTICS INC (PLRX) Stock Chart - ChartMill
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):